Standout Papers

Practice guideline recommendations summary: Disease-modifying therapies for adults with multiple scleros... 2018 2026 2020 2023 377
  1. Practice guideline recommendations summary: Disease-modifying therapies for adults with multiple sclerosis (2018)
    Alexander Rae‐Grant, Gregory S. Day et al. Neurology

Immediate Impact

6 from Science/Nature 62 standout
Sub-graph 1 of 21

Citing Papers

Tolebrutinib in Nonrelapsing Secondary Progressive Multiple Sclerosis
2025 Standout
Neutrophil Membrane‐Camouflaged Polyprodrug Nanomedicine for Inflammation Suppression in Ischemic Stroke Therapy
2024 Standout
4 intermediate papers

Works of David Jones being referenced

The sequence of disease-modifying therapies in relapsing multiple sclerosis: safety and immunologic considerations
2017
Overview and safety of fingolimod hydrochloride use in patients with multiple sclerosis
2014
and 2 more

Author Peers

Author Last Decade Papers Cites
David Jones 864 298 343 34 1.6k
Sherilyn A. Gross 118 35 8 33 1.4k
Mark Brincat 155 50 5 34 1.8k
Ping Liu 179 18 11 71 1.4k
Xin‐Feng Zheng 301 10 11 44 1.3k
John H. Bland 237 7 8 59 1.8k
Cecilia Nilsson 82 76 11 37 1.5k
Weina Li 16 27 7 48 1.2k
Olav A. Haugen 154 5 23 64 1.9k
Wei Wang 88 11 18 93 2.0k
Tsuneo Deguchi 77 4 28 50 1.9k

All Works

Loading papers...

Rankless by CCL
2026